Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer

19 Mar 2024

Abstract excerpt

The Scottish study of Palmer et al., published in the current issue of this journal, linking vaccination files with cervical cancer screening data and the national cancer registry, demonstrates excellent protection against invasive cervical cancer among girls immunized at the age of 12 to 13 years with the bivalent human papillomavirus (HPV) vaccine (Cervarix, GSK, Rixensart, Belgium) (1). The study completes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AI in cancer detection
Share to Cervical Cancer and HPV Research
Share to Hepatitis B Virus Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38501990
DOI: 10.1093/jnci/djae042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancerPMID 38501990Read ↗

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.Semantic proximity Read ↗

Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.Semantic proximity Read ↗

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.Semantic proximity Read ↗

UK population based study to predict impact of HPV vaccination.Semantic proximity Read ↗

Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study).Semantic proximity Read ↗

Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV TypesSemantic proximity Read ↗

[The follow up of the women vaccinated against HPV].Semantic proximity Read ↗

Spontaneous preterm birth risk among HPV ‐vaccinated and ‐unvaccinated women: a nationwide retrospective cohort study of over 240 000 singleton birthsSemantic proximity Read ↗

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.Semantic proximity Read ↗

Short-term reproducibility and comparative screening performance of paired cervical HPV DNA tests among women in SenegalSemantic proximity Read ↗

Evidence from Outcomes: Gender-Neutral 2vHPV Vaccination at Moderate Coverage Drives Rapid Depletion of HPV16/18 Among Vaccinated and Unvaccinated Women.Semantic proximity Read ↗

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.